RESUMO
We have recently developed a candidate HIV-1 vaccine based on virus-like particles (VLPs) expressing a gp120 from an Ugandan HIV-1 isolate of the clade A (HIV-VLP(A)s). In vivo immunogenicity experiments were performed in Balb/c mice, with an immunization schedule based on a multiple-dose regimen of HIV-VLP(A)s without adjuvants, showing a significant induction of both humoral and cellular immunity. The Env-specific cellular response was investigated in vitro, scoring for both the proliferative response of T helper cells and the cytolytic activity of cytotoxic T lymphocytes (CTLs). Furthermore, immune sera showed >50% neutralization activity against both the autologous field isolate and the heterologous T cell adapted B-clade HIV-1(IIIB) viral strain. This is one of the first examples of HIV-1 vaccines based on antigens derived from the A clade, which represents >25% of all isolates identified world wide. In particular, the A clade is predominant in sub-Saharan countries, where 70% of the global HIV-1 infections occur, and where vaccination is the only rational strategy for an affordable prevention against HIV-1 infection.
Assuntos
Vacinas contra a AIDS/imunologia , Proteína gp120 do Envelope de HIV/imunologia , Infecções por HIV/imunologia , HIV-1/imunologia , Linfócitos T Citotóxicos/imunologia , Vacinas contra a AIDS/uso terapêutico , Animais , Anticorpos Antivirais/biossíntese , Anticorpos Antivirais/sangue , Baculoviridae/genética , Ensaio de Imunoadsorção Enzimática , Epitopos/imunologia , Infecções por HIV/prevenção & controle , HIV-1/genética , Humanos , Imunização , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Testes de Neutralização , Proteínas Recombinantes/genética , Proteínas Recombinantes/imunologia , Linfócitos T Auxiliares-Indutores/imunologiaRESUMO
BACKGROUND: Genital cancers in Uganda have been the most frequently diagnosed cancer in men as well as in women since the 1950s. Genetic studies have detected HPV-16 variants of Af1 class and identified a new sub-class designated Af1-u. OBJECTIVES: The main goal of this study is to analyze the prevalence of HPV strains and HPV variants in anogenital lesions of Ugandan male and female subjects in order to possibly determine their role in the pathogenesis of such lesions and to develop an Ugandan preventive HPV vaccine program. STUDY DESIGN: The study is planning to enroll male and female subjects affected by genital lesions, in particular to collect 200 scrapes/biopsies from women with normal ectocervical epithelium as well as with all different degrees of ectocervical lesions (from CIN 1/LSIL to cervical carcinoma). All samples are analyzed by PCR amplification of the L1 conserved region (nt 6584-7035) and the E6/E7 genes (nt 34-880), nucleotide sequence analysis, homology and phylogenetic studies. Variant distribution studies will be followed by serological studies of prevalence and incidence in 1000 women. PRELIMINARY RESULTS AND CONCLUSIONS: Penile cancers from the Kyadondo County have been analyzed for the presence of HPV sequences. More recently 16 ectocervical scrapes and three biopsies have been received from women attending the Nsambya Hospital and analyzed for the presence and type of HPVs. Our results, obtained by PCR and sequencing analysis, allowed the identification of HPV-16 Af1 sequences in 100% of tumor tissue and in 6.25% of scrapes. HPV 45 was identified only in one tumor together with HPV 16 infection. HPV 33 and HPV 58 were present in 20% and 40%, respectively of HPV positive benign samples. The results are showing a narrowing of the HPV pattern in more advanced lesions, suggesting that mainly HPV-16 Af1 patients are progressing to cancer.
Assuntos
Papillomaviridae/genética , Infecções por Papillomavirus/virologia , Neoplasias Penianas/virologia , Infecções Tumorais por Vírus/virologia , Neoplasias do Colo do Útero/virologia , Feminino , Genes Virais , Variação Genética , Humanos , Masculino , Proteínas Oncogênicas Virais/genética , Papillomaviridae/classificação , Filogenia , Mutação Puntual , Reação em Cadeia da Polimerase , Análise de Sequência de DNA , Uganda/epidemiologiaRESUMO
To better characterize the virus isolates associated with the HIV-1 epidemic in Uganda, 100 specimens from HIV-1-infected persons were randomly selected from each of two periods from late 1994 to late 1997. The 200 specimens were classified into HIV-1 subtypes by sequence- based phylogenetic analysis of the envelope (env) gp41 region; 98 (49%) were classified as env subtype A, 96 (48%) as D, 5 (2.5%) as C, and 1 was not classified as a known env subtype. Demographic characteristics of persons infected with the two principal HIV-1 subtypes, A and D, were very similar, and the proportion of either subtype did not differ significantly between early and later periods. Our systematic characterization of the HIV-1 epidemic in Uganda over an almost 3-year period documented that the distribution and degree of genetic diversity of the HIV subtypes A and D are very similar and did not change appreciably over that time.
Assuntos
Síndrome da Imunodeficiência Adquirida/epidemiologia , HIV-1/classificação , Síndrome da Imunodeficiência Adquirida/virologia , Adulto , Feminino , HIV-1/genética , Humanos , Masculino , Filogenia , Uganda/epidemiologiaRESUMO
To better understand the emergence of subtype C and its potential impact on vaccine efforts in Uganda, we have characterized subtype C sequences from Uganda (n = 13), Zimbabwe (n = 11), Mozambique (n = 5), South Africa (n = 4), and India (n = 3). Phylogenetic analysis of subtype C sequences in the env gp41 gene region revealed multiple subclusters within subtype C. Further, while most Ugandan specimen subclustered together, other subclusters did not reflect a clear geographic location. The nucleotide divergence within the Ugandan subset was 8.2% (6.1-9.8%) compared with 9.5% (2.5-15%) for the other subtype C gp41 sequences. The protein sequence alignment revealed marked sequence conservation of major immunodominant epitopes within the gp41 region.
Assuntos
Proteína gp41 do Envelope de HIV/genética , Infecções por HIV/virologia , HIV-1/classificação , HIV-1/genética , Filogenia , Humanos , Dados de Sequência Molecular , Análise de Sequência de DNA , UgandaRESUMO
The AIDS Information Center (AIC) was established in Kampala, Uganda in 1990 in response to increasing interest by members of the general public who wished to know their HIV serostatus. By 1996, >300,000 clients had been seen. HIV serologic testing was performed at a central laboratory and results reported back to AIC after 2 weeks. Approximately 25% of clients failed to learn their HIV serostatus as a result of failure to return or late arrival of results. To address these issues, AIC carried out an evaluation of 3 rapid HIV assays, Sero-Strip, SeroCard, and Capillus, against a standard criterion to identify a testing algorithm that could be used as an on-site confirmatory testing strategy. The study was carried out over a period of 5 working days and 325 clients were seen. An algorithm was identified, which gave no indeterminate results with unambiguously positive or negative specimens, which was 100% sensitive and specific, and which could be integrated with minimal disruption into existing counseling procedures. All clients left AIC knowing their HIV serostatus and having spent <2 hours at the Center. The results of this evaluation demonstrate that "same-day" results can be provided in counseling and testing settings without compromising the quality of counseling or the accuracy of HIV testing.
PIP: An evaluation conducted at the AIDS Information Center in Kampala, Uganda, demonstrated that same-day HIV results can be provided in counseling and testing centers without compromising service quality. The Center was established in 1990 in response to widespread public interest in HIV serodiagnosis. By 1996, more than 300,000 clients had been tested. However, 25% of these clients never received their result because of failure to report back to the Center after 2 weeks (the time required for results to be returned from an off-site laboratory) or late arrival of results. To address this problem, the Center evaluated three rapid HIV assays (Sero-Strip, SeroCard, and Capillus) against a standard criterion to identify a testing algorithm that could be used as an on-site confirmatory testing strategy. 325 clients were enrolled in the 5-day evaluation. Individually, all three rapid tests performed well when compared with the standard criterion result. The resulting algorithm (a combination of Capillus as the screening assay and SeroCard as a supplementary assay for initially positive specimens and Multispot as a tie-breaker assay) gave no indeterminate results, was 100% sensitive and specific, and could be integrated easily into existing counseling protocols. The entire process (registration, test decision counseling, phlebotomy, laboratory testing, prevention counseling, and post-test counseling) took an average of 2 hours to complete.
Assuntos
Algoritmos , Aconselhamento/normas , Serviços de Diagnóstico/normas , Anticorpos Anti-HIV/sangue , Infecções por HIV/diagnóstico , Infecções por HIV/psicologia , Infecções por HIV/terapia , Humanos , Sensibilidade e Especificidade , Fatores de Tempo , UgandaRESUMO
OBJECTIVE: Previous data, based on a small sampling of convenience, reported subtypes A, B, C, D, and G in Uganda, but neither the extent nor the proportion of these subtypes could be evaluated. To establish correctly the prevalence and distribution of HIV-1 subtypes, we analysed viral clades in 739 HIV-1-seropositive specimens from different areas of Uganda. METHODS: Blood specimens from 1100 patients were collected in five districts of Uganda. Within this collection, 929 HIV-1-seroreactive samples underwent analysis of viral DNA, and 739 were selected for further subtyping in env or pol regions. RESULTS: Using a combination of subtype A- and D-specific probes to C2-V3 region and DNA sequencing, HIV-1 env subtypes were determined in 594 specimens: 341 were of subtype A (57.4%), 250 of subtype D (42.1%), and three of subtype C (0.5%). Sixty-two samples showed reactivity with both probes, suggesting potential mixed infections, cross-reactivity to probes, or possibly other subtypes. Subsequent sequence analysis of 19 randomly selected specimens revealed subtypes A (n = 4), D (n = 12), and C (n = 3). Sequence analysis of the 27 samples chosen from the remaining 83 samples, which could be amplified only with viral gp41 or protease gene primers, classified them as subtypes A (n = 13) and D (n = 14). No significant clinical, demographic, or geographic differences were found between HIV-1 infections with viruses of subtypes A and D, despite considerable genetic diversity within these clades. CONCLUSIONS: This is the first major population-based study of the prevalent HIV-1 strains in an African country selected for vaccine trials. The subtyping methods we describe should be of use to investigators seeking to conduct large-scale screening for HIV variants in other populations.
Assuntos
Infecções por HIV/epidemiologia , HIV-1/genética , Epidemiologia Molecular , Adulto , Sondas de DNA , DNA Viral , Feminino , Genes env , Variação Genética , HIV-1/classificação , Humanos , Masculino , Filogenia , Reação em Cadeia da Polimerase , Análise de Sequência de DNA , Uganda/epidemiologiaAssuntos
Infecções por Alphavirus/epidemiologia , Surtos de Doenças , Alphavirus/imunologia , Alphavirus/isolamento & purificação , Alphavirus/patogenicidade , Infecções por Alphavirus/etiologia , Infecções por Alphavirus/transmissão , Animais , Anticorpos Antivirais/sangue , Artrite Infecciosa/etiologia , Culicidae/virologia , Feminino , Febre/etiologia , Humanos , Masculino , Camundongos , Gravidez , Fatores de Tempo , Uganda/epidemiologiaRESUMO
The identification of Kaposi's sarcoma (KS) clusters in sub-equatorial Africa (endemic KS, AKS) and the high frequency of KS in sexually transmitted AIDS (epidemic KS, EKS), have previously suggested a role for infectious agents in the etiopathogenesis of KS. The recent identification of herpesvirus (HHV)-like DNA sequences in one case of EKS and their detection in > 90% of all tested EKS, prompted us to determine the prevalence of these viral sequences in all types of KS, such as AKS, EKS, classic KS (CKS) and iatrogenic KS (IKS). The presence of herpesvirus(HHV)-like DNA sequences has been examined in 61 KS skin tumors obtained from Greece, Italy, USA, Uganda and Kenya. All KS types (100%) were positive by polymerase chain reaction (PCR) and Southern-blot analysis, while 5 out of 6 (83%) and 4 out of 7 (57%) uninvolved autologous skin biopsies from AKS and CKS patients, respectively, were positive for HHV-like sequences. All samples from non-KS patients were negative, i.e. 17 human biopsies from healthy individuals or patients affected by other pathologies, 5 human cell lines and 15 peripheral blood mononuclear cells (PBMC) from HIV-positive subjects. These results suggest that HHV-like sequences play a major role in the pathogenesis of this neoplasm.
Assuntos
Herpesviridae/genética , Sarcoma de Kaposi/microbiologia , Neoplasias Cutâneas/microbiologia , DNA Viral/análise , Humanos , Reação em Cadeia da Polimerase , Sarcoma de Kaposi/etiologia , Pele/microbiologia , Neoplasias Cutâneas/etiologia , Células Tumorais CultivadasRESUMO
Positively charged amino acid substitutions at positions 11 and 25 within the loop of the third variable region (V3) of HIV-1 subtype B envelope have been shown to be associated with the syncytium-inducing (SI) phenotype of the virus. The present study was designed to examine SI and NSI-associated V3 mutations in HIV-1 subtypes other than B. HIV-1 RNA was isolated from 53 virus stocks and 26 homologous plasma samples from 53 recently infected individuals from Brazil, Rwanda, Thailand, and Uganda. The C2-V3 region of the viral envelope was converted to cDNA, amplified, and sequenced. Of 53 primary virus stock samples 49 were biologically phenotyped through measurement of the syncytium-inducing capacity in MT-2 cells (to differentiate between SI and NSI phenotypes). In addition, after passage of primary isolates through PHA stimulated donor PBMC, the replication capacity was determined in U937-2, CEM, MT-2, and Jurkat-tat cell lines (to differentiate rapid/high and slow/low phenotypes). According to the sequence analysis 9 (17.0%) of the viruses belonged to subtype A, 15 (28.3%) to subtype B, 1 (1.9%) to subtype C, 13 (24.5%) to subtype D, and 15 (28.3%) to subtype E. Sequence analysis of virus RNA, obtained from 26 homologous plasma samples, confirmed the homogeneity of sequence populations in plasma compared to primary virus isolates. Of the 49 viruses tested 12 had the SI phenotype, 5 were confirmed to be rapid/high, and 4 appeared to be slow/low pattern 3 replicating. Of 49, 29 had the NSI phenotype, 24 were confirmed to be slow/low pattern 1 or 2, and 3 appeared to be slow/low pattern 3 replicating. Analysis of mutations at V3 loop amino acid positions 11 and 25 revealed that 10/12 (83.3%) of the SI viruses had SI-associated V3 mutations and that 28/29 (96.6%) of the NSI viruses lacked these mutations. V3 loop heterogeneity, length polymorphism, and a high number of positively charged amino acid substitutions were most frequently found among subtype D variants. These results indicate that both the phenotypic distinction between SI and NSI viruses and the association of biological phenotype with V3 mutations is present among HIV-1 subtypes other than B.
Assuntos
HIV-1/patogenicidade , Adulto , Sequência de Aminoácidos , Sequência de Bases , Brasil/epidemiologia , Linhagem Celular , Efeito Citopatogênico Viral/genética , DNA Viral/genética , Feminino , Genes env , Genótipo , Proteína gp120 do Envelope de HIV/genética , Infecções por HIV/epidemiologia , Infecções por HIV/virologia , HIV-1/classificação , HIV-1/genética , Humanos , Masculino , Dados de Sequência Molecular , Fragmentos de Peptídeos/genética , Fenótipo , Filogenia , Ruanda/epidemiologia , Homologia de Sequência de Aminoácidos , Tailândia/epidemiologia , Uganda/epidemiologia , Replicação Viral/genéticaRESUMO
We compared 1616 sera from HIV-1-infected subjects and matched HIV-negative local controls in Uganda, Kenya and the UK. Sera were screened for specific antibody to HIV-1 p24 Gag and gp120 Env proteins and for p24 antigenaemia. In contrast to the UK, the majority of African HIV-1-infected subjects maintained detectable anti-p24 antibodies. However, lower reactivity of anti-p24 was observed in African AIDS patients, compared with those with asymptomatic HIV-1 infection. This reduction in anti-p24 reactivity with more advanced clinical stage was less marked in African HIV-1 infection than in the UK. Correspondingly, p24 antigenaemia was more common in patients with AIDS from the UK than in African patients (65 versus 4%). Reductions in anti-gp120 reactivity were observed in African AIDS patients, compared with the asymptomatic group. However, median reactivity of anti-gp120 in UK patients remained unchanged in both asymptomatic and AIDS subjects. The differences in humoral response to p24 and gp120 between Africa and the UK are semi-quantitative rather than qualitative and could be explained by initial higher antibody response to HIV-1 in African subjects.
Assuntos
Anticorpos Anti-HIV/biossíntese , Infecções por HIV/imunologia , HIV-1/imunologia , Estudos Transversais , Proteína do Núcleo p24 do HIV/imunologia , Proteína gp120 do Envelope de HIV/imunologia , Infecções por HIV/epidemiologia , Humanos , Quênia/epidemiologia , Masculino , Uganda/epidemiologia , Reino Unido/epidemiologiaRESUMO
In the USA and Europe, toxoplasmosis is well recognized as an important cause of morbidity and mortality among immunocompromised individuals. Toxoplasma gondii has been shown to be a common opportunistic infection in patients infected with the human immunodeficiency virus (HIV) in the USA and Europe with published estimates ranging from 20% to 80%. The importance of Toxoplasma infection in East Africa has not yet been defined. The seroprevalence rates of toxoplasmosis in Zambian and Ugandan patients were determined using the dye test (DT) and the latex agglutination test (LAT). The geographical variation in seroprevalence rates noted in western countries was also found in these African countries, with Zambia showing significantly lower rates than Uganda. 34% of Ugandan (64/186) and 4% of Zambian (8/187) patients infected with HIV, compared with 27% of Ugandan (26/93) and 11% of Zambian (20/189) HIV-negative persons, had anti-Toxoplasma immunoglobulin G antibodies. With the LAT, 13% of the Ugandan and 7% of the Zambian sera gave a false positive result. The relevance of Toxoplasma serology in Africa is discussed.
Assuntos
Infecções por HIV/complicações , Infecções Oportunistas/epidemiologia , Toxoplasmose/epidemiologia , Anticorpos Antiprotozoários/análise , Feminino , Infecções por HIV/epidemiologia , Infecções por HIV/imunologia , Humanos , Masculino , Infecções Oportunistas/complicações , Infecções Oportunistas/imunologia , Estudos Soroepidemiológicos , Toxoplasmose/complicações , Toxoplasmose/imunologia , Uganda/epidemiologia , Zâmbia/epidemiologiaRESUMO
Risk factor data were collected in 1,328 inpatients and outpatients in 1987 in 15 hospitals throughout Uganda; 42% were positive for HIV antibodies by ELISA. Seropositivity was associated with urban residence, sexually transmitted diseases (STD), number of sex partners, and sex for payment or with a person with an AIDS-like illness. Homosexuality and intravenous drug abuse, recognized risk factors in western countries, were not seen as risk factors. By multivariate analysis, urban residence and sex for payment were not independently associated with infection. Among females, number of sex partners, sex with a person with an AIDS-like illness, and numbers of episodes of STDs were significantly associated with seropositivity. In males, similar associations were seen, although number of reported sex partners was not independently associated with infection. These findings support the view that heterosexual contact is the predominant mode of transmission in Uganda and suggest that the main risk factors relate to high-risk heterosexual behavior.
Assuntos
Síndrome da Imunodeficiência Adquirida/epidemiologia , Anticorpos Anti-HIV/análise , Síndrome da Imunodeficiência Adquirida/complicações , Síndrome da Imunodeficiência Adquirida/imunologia , Síndrome da Imunodeficiência Adquirida/transmissão , Adolescente , Adulto , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Criança , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Análise de Regressão , Fatores de Risco , Fatores Sexuais , Trabalho Sexual , Parceiros Sexuais , Infecções Sexualmente Transmissíveis/complicações , Uganda , População UrbanaRESUMO
Infections with human immunodeficiency virus are common in areas of the world where laboratory testing and sophisticated diagnostic facilities are unavailable. A World Health Organization clinical case definition for acquired immunodeficiency syndrome was developed in 1985 for use in such areas. In 1987, we tested this definition on 1328 inpatients and outpatients in 15 hospitals throughout Uganda. Five hundred sixty-two patients (42%) were positive by enzyme-linked immunosorbent assay for human immunodeficiency virus antibody. The World Health Organization definition had a sensitivity of 55%, a specificity of 85%, and a positive predictive value of 73%. Modification of the case definition by excluding a known cough from tuberculosis as a minor criteria decreased sensitivity slightly to 52%, but specificity and positive predictive value increased to 92% and 83%, respectively. Amenorrhea, although not specifically asked about, was a symptom noted by many female patients (26% of females who were positive by enzyme-linked immunosorbent assay); as a symptom indicative of human immunodeficiency virus infection, amenorrhea had a specificity of 99%, with a positive predictive value of 89%. These findings support the generalizability of the World Health Organization clinical acquired immunodeficiency syndrome definition and its use (especially the modified version) in areas of Uganda without sophisticated facilities.
Assuntos
Síndrome da Imunodeficiência Adquirida/diagnóstico , Sorodiagnóstico da AIDS , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Amenorreia/etiologia , Criança , Tosse/etiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Sensibilidade e Especificidade , Tuberculose Pulmonar/complicações , Uganda , Organização Mundial da SaúdeAssuntos
Aedes , Vírus Chikungunya , Insetos Vetores , Animais , Encéfalo , Haplorrinos , Testes de Inibição da Hemaglutinação , Macaca , Camundongos , Cultura de VírusAssuntos
Arbovírus/isolamento & purificação , Culicidae , Surtos de Doenças/epidemiologia , Insetos Vetores , Febre do Vale de Rift/epidemiologia , Zoonoses , Animais , Anticorpos Antivirais , Arbovírus/imunologia , Doenças das Aves/microbiologia , Aves , Bovinos , Doenças dos Bovinos/microbiologia , Culex , Humanos , Camundongos , Ratos , Febre do Vale de Rift/veterinária , Doenças dos Roedores/microbiologia , Roedores , Manejo de Espécimes , UgandaAssuntos
Infecções por Arbovirus/epidemiologia , Vírus Chikungunya/isolamento & purificação , Aedes , Animais , Infecções por Arbovirus/veterinária , Surtos de Doenças , Haplorrinos , Testes de Inibição da Hemaglutinação , Humanos , Imunidade , Insetos Vetores , Doenças dos Macacos/epidemiologia , Doenças dos Macacos/imunologia , Periodicidade , Estações do Ano , Uganda , Febre Amarela/imunologiaRESUMO
"In order to identify HIV-1 strains prevalent in Northern Uganda; peripheral blood mononuclear cells (PBMC) of 19 asympotomatic seropositive pregnant women from the District of Gulu-Northern Uganda have been analysed. A 700bp fragment of the HIV-1 env gene; including the V3-V5 region; amplified by Polymerase chain Reaction (PCR) from 10 samples (52.6); was subjected to both heteroduplex Mobility Assay (HMA); for genetic subtyping; and DNA sequence analysis; for nucleotide comparison and phylogenetic studies. The results show the presence of HIV-1 ""A"" and ""D"" subtypes/clades with a strong prevalence; in this rural area; of the ""A""(8/10) over the ""D"" subtype (2/10) unlike what was previously reported in Uganda. By pairwise comparison analysis; the percentage of sequence divergence is low among samples within each subtype (average inter-subtypes divergence of 23). At the aminoacidic level; the two HIV-1 groups are clearly distinct by a tetrameric GPGQ sequence at the V3 loop apex for the A and a GPGR sequence for the D clade. In addition; 10 out of the 19 viral samples (52.6) have been isolated in vitro and 9 of them have been classified as Rapid/High (R/H); showing the high in vitro replication capacity to field isolated also when obtained from asymptomatic individuals. These data; even though on a limited sample size; suggest that in Uganda HIV-1 isolates can be prevalently grouped in 2 major clades; and the comparison of Gulu HIV-1 sequences with the two consensus sequences (Group A and B) identified by Albert et al 1990; indicates that in a 4-year period no major genetic shifts have occurred. These results should be extremely relevant for Uganda future HIV-1 vaccine programs. Supported by Ministero Italiano Sanita (Ric.Corr.1994) and ISDC-World Laboratory; Lausanne (Project MCD-2/7)."